Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study

By Van Ganse Eric   Laforest Laurent   Alemao Evo   Davies Glenn   Gutkin Stephen   Yin Don  

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1389-1400

Informa Healthcare

Access to resources Recommend Favorite

Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy

By Shepherd James   Packard Chris   Littlejohn Thomas W.   Walker James   Stein Evan A.   Smith Karen   Kallend David   Blasetto James W.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1571-1578

Informa Healthcare

Access to resources Recommend Favorite

Alternate approaches to managing lipid-associated cardiovascular risk

By Hsia Stanley H  

Future Lipidology, Vol. 2, Iss. 2, 2007-04 ,pp. : 157-163

Future Medicine

Access to resources Recommend Favorite

The Effects of Isolated versus Multiple Lipid Disorders on Resource Utilization among Metabolic Syndrome Patients with Lipid Abnormalities despite Lipid-Modifying Treatment

By  

Cardiology, Vol. 117, Iss. 2, 2010-10 ,pp. : 96-104

Karger

Access to resources Recommend Favorite

Reduction of cholesterol and other cardiovascular disease risk factors by alternative therapies

By Tappia Paramjit S   Xu Yan-Jun   Dhalla Naranjan S  

Clinical Lipidology, Vol. 8, Iss. 3, 2013-06 ,pp. : 345-359

Future Medicine

Access to resources Recommend Favorite